Tobacco Smoking and Brain Endogenous Opioid Release: More Than Nicotine Alone
- PMID: 29514324
- PMCID: PMC6528147
- DOI: 10.1093/ntr/nty039
Tobacco Smoking and Brain Endogenous Opioid Release: More Than Nicotine Alone
Abstract
Introduction: The effects of smoking denicotinized (denic) and average nicotine (avnic) tobacco cigarettes were studied on brain mu opioid receptor binding by positron emission tomography with 11C carfentanil. The results indicated the importance of physiological and psychological effects induced by denic smoking.
Methods: Regional mu opioid binding potential (nondisplaceable binding potential, BPND) was measured in 20 adult male overnight abstinent chronic tobacco smokers. The denic sessions were conducted about 8:00 am followed by avnic sessions about 2 hours later. Venous plasma nicotine levels and scores of craving to smoke were assessed before and after each smoking session. Fagerstrom scores of nicotine dependence were determined. Pearson's and Spearman's correlation tests were used to examine associations between BPND and other smoking parameters.
Results: Surprisingly, the very low plasma nicotine peak levels after denic smoking (mean ± SD: 3.3 ± 1.8 ng/mL) were significantly correlated with BPND after denic and avnic smoking. Equally surprising no association was found between nicotine levels after avnic smoking and BPND. Delta craving scores and Fagerstrom scores were correlated with both BPND after denic and avnic in several brain regions.
Conclusions: Very small amounts of nicotine, psychological and behavioral effects of denic smoking appear to have important actions on the endogenous mu opioid system.
Implications: Associations between very low venous plasma nicotine levels after denic smoking and regional brain mu opioid receptor availability are a surprising "placebo" effect. Delta craving and Fagerstrom scores were correlated with BPND in several brain regions including amygdala, hippocampus, insula, nucleus accumbens, putamen, and ventral striatum. This study is limited by modest Power (mean 1 - β = 0.6) for all correlation analyses.
© The Author(s) 2018. Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Figures


Similar articles
-
Nicotine-specific and non-specific effects of cigarette smoking on endogenous opioid mechanisms.Prog Neuropsychopharmacol Biol Psychiatry. 2016 Aug 1;69:69-77. doi: 10.1016/j.pnpbp.2016.04.006. Epub 2016 Apr 17. Prog Neuropsychopharmacol Biol Psychiatry. 2016. PMID: 27095017 Free PMC article.
-
Regional brain [(11)C]carfentanil binding following tobacco smoking.Prog Neuropsychopharmacol Biol Psychiatry. 2015 Jun 3;59:100-104. doi: 10.1016/j.pnpbp.2015.01.007. Epub 2015 Jan 15. Prog Neuropsychopharmacol Biol Psychiatry. 2015. PMID: 25598501 Free PMC article.
-
Association of smoking with μ-opioid receptor availability before and during naltrexone blockade in alcohol-dependent subjects.Addict Biol. 2014 Jul;19(4):733-42. doi: 10.1111/adb.12022. Epub 2012 Dec 18. Addict Biol. 2014. PMID: 23252742 Free PMC article.
-
Tobacco/nicotine and endogenous brain opioids.Prog Neuropsychopharmacol Biol Psychiatry. 2008 Jul 1;32(5):1131-8. doi: 10.1016/j.pnpbp.2007.12.012. Epub 2007 Dec 23. Prog Neuropsychopharmacol Biol Psychiatry. 2008. PMID: 18215788 Free PMC article. Review.
-
Endogenous opioid system: a promising target for future smoking cessation medications.Psychopharmacology (Berl). 2017 May;234(9-10):1371-1394. doi: 10.1007/s00213-017-4582-0. Epub 2017 Mar 11. Psychopharmacology (Berl). 2017. PMID: 28285326 Review.
Cited by
-
Nicotine and opioid co-dependence: Findings from bench research to clinical trials.Neurosci Biobehav Rev. 2022 Mar;134:104507. doi: 10.1016/j.neubiorev.2021.12.030. Epub 2021 Dec 27. Neurosci Biobehav Rev. 2022. PMID: 34968525 Free PMC article. Review.
-
Childhood family environment and μ-opioid receptor availability in vivo in adulthood.Neuropsychopharmacology. 2025 Jun;50(7):1130-1135. doi: 10.1038/s41386-025-02059-6. Epub 2025 Jan 31. Neuropsychopharmacology. 2025. PMID: 39890998 Free PMC article.
References
-
- Scott DJ, Domino EF, Heitzeg MM, et al. . Smoking modulation of mu-opioid and dopamine D2 receptor-mediated neurotransmission in humans. Neuropsychopharmacology. 2007; 32(2): 450–457. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials